Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71.3M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
44.4M
-
Shares change
-
+134K
-
Total reported value, excl. options
-
$95.1M
-
Value change
-
+$2.06M
-
Put/Call ratio
-
0.73
-
Number of buys
-
61
-
Number of sells
-
-74
-
Price
-
$2.14
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q2 2025
151 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.4M shares
of 71.3M outstanding shares and own 62.29% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (5.9M shares), Affinity Asset Advisors, LLC (4.54M shares), VANGUARD GROUP INC (3.16M shares), TANG CAPITAL MANAGEMENT LLC (3.1M shares), MARSHALL WACE, LLP (2.4M shares), Vestal Point Capital, LP (2M shares), CITADEL ADVISORS LLC (1.77M shares), MILLENNIUM MANAGEMENT LLC (1.41M shares), BlackRock, Inc. (1.37M shares), and Sio Capital Management, LLC (1.31M shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.